Lipella Pharmaceuticals Inc. (LIPO) stock
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lipella Pharmaceuticals's enterprise value was -$1.85M on Oct 19, 2026, against -$838.51K a year earlier. Over the last 4 years it ranged from -$2.44M to $10.39M, with a median of $1.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | -$1.85M | – |
| 2025 | Dec 31, 2025 | -$1.02M | -151.9% |
| 2024 | Dec 31, 2024 | $1.97M | -43.8% |
| 2023 | Dec 29, 2023 | $3.51M | -66.2% |
| 2022 | Dec 30, 2022 | $10.39M | – |
See a number that looks wrong?